MetaCap

OptimizeRx (OPRX) vs Paysafe (PSFE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

OptimizeRx (OPRX) has outperformed Paysafe (PSFE) over the past year, losing 54.1% versus a loss of 61.7%. Over five years, OPRX leads with a -90.2% price change compared with -94.1% for PSFE. Paysafe is the larger company by market cap ($143.3 million vs $126.7 million), about 1.1 times the size, while OptimizeRx is growing revenue faster (+18.8% vs -0.2%).

On valuation, Paysafe trades at a lower forward P/E (1.8x vs 6.4x for OptimizeRx). OptimizeRx converts more of its revenue into profit, with a net margin of 4.7% versus -10.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OPRX-54.08%PSFE-61.73%
+36%-19%-74%
Nov 21, 20251 yearNov 20, 2026
OPRX-90.66%PSFE-94.15%
+9%-45%-100%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OPRX versus PSFE key metrics
MetricOPRXPSFE
Share price$6.70$2.74
Market cap$126.68M$143.29M
1-day change-4.42%-9.57%
YTD return-45.35%-66.13%
1-year return-54.08%-61.73%
5-year return-90.22%-94.13%
P/E ratio (TTM)25.77—
Forward P/E6.371.78
EPS (TTM)$0.26$-7.08
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$109.43M$1.70B
Revenue growth (YoY)+18.78%-0.20%
Net income (latest FY)$5.13M$-182.51M
Gross margin67.25%56.44%
Operating margin10.69%4.23%
Net margin4.69%-10.73%
52-week high$15.59$10.04
52-week low$4.54$2.72
Distance from 52-week high-57.02%-72.71%
Analyst consensusstrong_buyhold
Avg. price target upside+77.61%+100.73%
Average volume190.65K466.35K
Shares outstanding18.91M52.30M
Employees1322,800
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • OptimizeRx is more profitable, keeping 4.7 cents of every revenue dollar as net income versus -10.7 cents for Paysafe.
  • OptimizeRx grew revenue faster in its latest fiscal year (+18.78% vs -0.20%).

About OptimizeRx

OPRX stock →

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.

Consumer Discretionary · Business Services · 132 employees

About Paysafe

PSFE stock →

Paysafe Limited provides digital payment solutions in the United States, Germany, the United Kingdom, and internationally. The company operates through two segments, Merchant Solutions and Digital Wallets.

Consumer Discretionary · Business Services · 2,800 employees

OPRX vs PSFE FAQ

Which is bigger, OptimizeRx or Paysafe?

Paysafe (PSFE) is larger, with a market capitalization of $143.29M compared with $126.68M for OptimizeRx (OPRX).

Which stock has performed better over the past year, OPRX or PSFE?

OPRX returned -54.08% over the past 12 months, compared with -61.73% for PSFE (price return, excluding dividends). Past performance does not predict future results.

Are OptimizeRx and Paysafe in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons